BioTraceIT Corporation – Trademark Portfolio

Entity Type: 03

BioTraceIT Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PAINTRACE and BIOTRACEIT. The owner is based in Commack, NY.

366 Veterans Memorial Hwy

Commack, NY 11725

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BioTraceIT Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does BioTraceIT Corporation have?

BioTraceIT Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does BioTraceIT Corporation file in?

BioTraceIT Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are BioTraceIT Corporation's most well-known trademarks?

BioTraceIT Corporation's registered trademark portfolio includes well-known marks such as PAINTRACE and BIOTRACEIT. These are among 2 currently registered trademarks in the portfolio.

What is BioTraceIT Corporation's trademark registration success rate?

BioTraceIT Corporation has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.